CELZ · Creative Medical Technology Holdings, Inc.
$0.86
-0.02 (-1.82%)
At close · Jul 20
Market Cap
$3.19M
Shares
3.70M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$6000
-45.5%
FY2025
Net Income
-$6M
-9.1%
FY2025
Gross Margin
63.43%
+3.4pp
FY2025
Operating Margin
-102380.23%
-50163.3pp
FY2025
Diluted EPS
-$2.52
+32.1%
FY2025
Operating Cash Flow
-$5.86M
-10.5%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $3000 | $6000 | $11K | $9000 | $88.6K | $87.75K | $164.5K | $165.5K | $124.4K | $4800 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| $994 | $2194 | $4400 | $3600 | $28.49K | $47.95K | $50.6K | $45.5K | $70.38K | $8000 | $0 | — | — | — | — | — | — | |
| $2006 | $3806 | $6600 | $5400 | $60.11K | $39.81K | $113.9K | $120K | $54.03K | -$3200 | $0 | — | — | — | — | — | — | |
| — | 63.43% | 60% | 60% | 67.84% | 45.36% | 69.24% | 72.51% | 43.43% | -66.67% | — | — | — | — | — | — | — | |
| $2.06M | $2.26M | $2.4M | $1.97M | $6.27M | $109.18K | $0 | $0 | $96.62K | $260.09K | $85.33K | — | — | — | — | — | — | |
| $1.17M | — | — | — | — | — | — | — | $1.05M | $898.53K | $664.98K | — | — | — | — | — | — | |
| $3.76M | $3.76M | $3.24M | $3.56M | $3.94M | $2.96M | $1.16M | $1.22M | $1.05M | — | — | — | — | — | — | — | — | |
| $121.61K | $123.33K | $110.45K | $94.58K | $92.08K | $92.08K | $66.79K | $26.95K | $21.14K | $16K | $9356 | — | — | — | — | — | — | |
| — | — | $56K | $56K | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $5.94M | $6.15M | $5.75M | $5.63M | $10.3M | $3.17M | $1.23M | $1.25M | $1.17M | $1.17M | $759.67K | $20.83K | $19.43K | $20.12K | $20.1K | $19.83K | $14.29K | |
| -$5.94M | -$6.14M | -$5.74M | -$5.62M | -$10.24M | -$3.13M | -$1.11M | -$1.13M | -$1.11M | -$1.18M | -$759.67K | -$20.83K | -$19.43K | -$20.12K | -$20.1K | -$19.83K | -$14.29K | |
| — | -102380.23% | -52216.92% | -62445.91% | -11562.5% | -3562.17% | -677.71% | -682.88% | -895.68% | -24537.62% | — | — | — | — | — | — | — | |
| — | — | -$5.69M | -$5.56M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | $0 | $4.28M | $1.23M | $1.9M | $1.36M | $377.59K | $6398 | — | — | — | — | — | — | |
| $180.86K | $147.81K | $250.38K | $333.56K | $100.33K | $22.34M | -$35.21M | -$7.35M | -$12.54M | -$1.48M | -$6398 | — | — | — | — | -$4225 | -$2966 | |
| -$5.76M | -$6M | -$5.49M | -$5.29M | -$10.14M | $19.21M | -$36.33M | -$8.48M | -$13.66M | -$2.66M | — | — | — | — | — | -$24.06K | -$17.26K | |
| $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | — | — | |
| -$5.76M | -$6M | -$5.49M | -$5.29M | -$10.14M | $19.21M | -$36.33M | -$8.48M | -$13.66M | -$2.66M | -$766.07K | -$30.76K | -$28.01K | -$27.28K | -$25.59K | -$24.06K | -$17.26K | |
| — | -99916.8% | -49940.74% | -58739.71% | -11449.26% | 21892.75% | -22082.21% | -5126.09% | -10977.21% | -55398.08% | — | — | — | — | — | — | — | |
| — | $0 | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | $19.21M | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | — | — | — | -$9.30 | $73.70 | -$626.90 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$2.52 | -$3.71 | -$3.76 | -$9.30 | $56.10 | -$626.90 | — | — | — | — | — | — | — | — | — | — |
| shares | — | — | — | — | 1.09M | 260.51K | 57.95K | 2068.6324 | 781.2448 | 141.7648 | 125.342 | 24.1517 | 24.1517 | 24.1517 | 24.1517 | — | — |
| shares | — | 2.38M | 1.48M | 1.41M | 1.09M | 324.86K | 57.95K | 2068.6324 | 781.2448 | 141.7648 | 125.342 | — | — | — | 24.1517 | 24.1517 | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2025: $455.92K in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.46×
EV/EBIT
—
Biotechnology median 26.45×
P/E (TTM)
—
Biotechnology median 7.03×